Max BioPharma - Crunchbase Company Profile & Funding

Q: Who invested in Max BioPharma?

Max BioPharma is funded by Technomark Life Sciences.

Q: When was the last funding round for Max BioPharma?

Max BioPharma closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Max BioPharma raised to date?

Max BioPharma has raised obfuscated.

Overview

Max BioPharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Max BioPharma

CB Rank

35249

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

Founded

obfuscation

Private

Series A

Santa Monica, California, United States

1-10

www.maxbiopharma.com

Biopharma

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Farhad Parhami: CEO, President,

Details

Legal Name

Max BioPharma

Operating Status

Active

Company Type

For Profit

Founders

Farhad Parhami

About the Company

MAX BioPharma is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols, as candidates for therapeutic drugs for debilitating and fatal human diseases. These oxysterol molecules belong to the family of sterols that have the ability to stimulate bone growth, block the growth of cancer cells, and

inhibit their ability to metastasize.

Predictions & Insights

Growth Insight

See this Growth Insight

Max BioPharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Product Launches

Products & Services

OxyFuse-133

An oxysterol-based investigational device that stimulates bone formation by targeting specialized stem cells, used for spine fusion procedures.

Oxy210

An orally bioavailable oxysterol-based drug candidate with antifibrotic and anti-inflammatory properties, developed for the treatment of non-alcoholic steatohepatitis (NASH).

Research & Development

Max BioPharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A
obfuscated obfuscation	Series A - Max BioPharma	1	obfuscated obfuscation	Technomark Life Sciences	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Technomark Life Sciences	Yes	Series A - Max BioPharma	Allen Hakimi
Technomark Life Sciences	Yes	Series A - Max BioPharma	Allen Hakimi
Technomark Life Sciences	Yes	Series A - Max BioPharma	Allen Hakimi
Technomark Life Sciences	Yes	Series A - Max BioPharma	Allen Hakimi
Technomark Life Sciences	Yes	Series A - Max BioPharma	Allen Hakimi